Product Safety Recalls

Product Recall Tracker

EPINEPHRINE Recall D-0764-2022

Description: SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.

EPINEPHRINE Recall D-0764-2022 Information

Mandated?Voluntary: Firm initiated
Recall NumberD-0764-2022
Event ID89778
Original Package?1
Active SubstanceEPINEPHRINE
DistributionNationwide in the U.S.A.
Quantity2,500 cartons
Recall ReasonDefective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Drug ClassificationClass I
Drug Code Info20220413
Product NDC78670-130 78670-131
Product NUIN0000000209 N0000000245 N0000175552
Pharma Class (EPC)alpha-Adrenergic Agonist [EPC]
Pharma Class (CS)Catecholamines [CS]
Recall Initiation Date20220321
Report Date20220413
Classification Date20220408
Address11682 El Camino Real Ste 300
San Diego, CA 92130-2092
United States
Recalling FirmAdamis Pharmaceuticals Corporation
Initial Notification Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Unique Ingredient IdentifierYKH834O4BH
Drug Application NumberNDA207534
Structured Product Labeling (SPL ID)b81ff52b-5ce1-4794-8ac6-8195e6360f9d
Structured Product Labeling (SPL Set ID)eeb2da6b-3fb3-48f6-bb62-ac3ad3b8fafa
Similar To

© 2021 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.